Cargando…
Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well
INTRODUCTION: During the COVID-19 pandemic, studies reported less number of hospitalizations for acute stroke and reduction in the use of recanalization treatments. This study analyzes nationwide data on stroke admissions and management in the Czech Republic during the first wave of the COVID-19 pan...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450853/ https://www.ncbi.nlm.nih.gov/pubmed/34515067 http://dx.doi.org/10.1159/000517968 |
_version_ | 1784569729975844864 |
---|---|
author | Sedova, Petra Brown Jr., Robert D. Bryndziar, Tomas Jarkovsky, Jiri Tomek, Ales Sramek, Martin Skoda, Ondrej Sramkova, Tereza Littnerova, Simona Mikulik, Robert |
author_facet | Sedova, Petra Brown Jr., Robert D. Bryndziar, Tomas Jarkovsky, Jiri Tomek, Ales Sramek, Martin Skoda, Ondrej Sramkova, Tereza Littnerova, Simona Mikulik, Robert |
author_sort | Sedova, Petra |
collection | PubMed |
description | INTRODUCTION: During the COVID-19 pandemic, studies reported less number of hospitalizations for acute stroke and reduction in the use of recanalization treatments. This study analyzes nationwide data on stroke admissions and management in the Czech Republic during the first wave of the COVID-19 pandemic. METHODS: We compared the early COVID-19 pandemic (March–May 2020) with the pre-pandemic period (January–February 2020 and March–May 2019): (a) the National Register of Reimbursed Health Services provided volume of all admissions for subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke (IS), and volume of recanalization treatments (intravenous thrombolysis [IVT] and mechanical thrombectomy [MT]); (b) Registry of Stroke Care Quality provided door-to-needle time (DNT), onset-to-door time (ODT), and stroke severity at admission (National Institutes of Health Stroke Scale, NIHSS) for IS. RESULTS: During the pandemic (March–May 2020), the peak number of COVID-19 patients treated in Czech hospitals was 39 per million. In March–May 2020 versus March–May 2019, hospital admissions decreased as follows: stroke overall by 14% (p < 0.001), IS by 14% (p < 0.001), SAH by 15% (p = 0.07), and ICH by 7% (p = 0.17). The mean age was 74 years versus 74 years (p = 0.33), and 52% versus 51% were men (p = 0.34). The volumes of IVT and MT decreased by 14% (p = 0.001) and 19% (p = 0.01), respectively. The proportions of all IS patients receiving IVT or MT remained unchanged, with, respectively, 17% versus 17% receiving IVT (p = 0.86) and 5% versus 5% receiving MT (p = 0.48). DNT and ODT were 24 versus 25 min (p = 0.58) and 168 versus 156 min (p = 0.23), respectively. NIHSS at admission did not differ (6 vs. 6; p = 0.54). CONCLUSION: Even with a low burden of COVID-19 during the first wave and no change in organization and logistics of stroke services, stroke admissions and volume of recanalization treatments decreased. Public health communication campaigns should encourage people to seek emergency medical care for stroke symptoms during the COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-8450853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-84508532021-09-23 Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well Sedova, Petra Brown Jr., Robert D. Bryndziar, Tomas Jarkovsky, Jiri Tomek, Ales Sramek, Martin Skoda, Ondrej Sramkova, Tereza Littnerova, Simona Mikulik, Robert Cerebrovasc Dis Clinical Research in Stroke INTRODUCTION: During the COVID-19 pandemic, studies reported less number of hospitalizations for acute stroke and reduction in the use of recanalization treatments. This study analyzes nationwide data on stroke admissions and management in the Czech Republic during the first wave of the COVID-19 pandemic. METHODS: We compared the early COVID-19 pandemic (March–May 2020) with the pre-pandemic period (January–February 2020 and March–May 2019): (a) the National Register of Reimbursed Health Services provided volume of all admissions for subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke (IS), and volume of recanalization treatments (intravenous thrombolysis [IVT] and mechanical thrombectomy [MT]); (b) Registry of Stroke Care Quality provided door-to-needle time (DNT), onset-to-door time (ODT), and stroke severity at admission (National Institutes of Health Stroke Scale, NIHSS) for IS. RESULTS: During the pandemic (March–May 2020), the peak number of COVID-19 patients treated in Czech hospitals was 39 per million. In March–May 2020 versus March–May 2019, hospital admissions decreased as follows: stroke overall by 14% (p < 0.001), IS by 14% (p < 0.001), SAH by 15% (p = 0.07), and ICH by 7% (p = 0.17). The mean age was 74 years versus 74 years (p = 0.33), and 52% versus 51% were men (p = 0.34). The volumes of IVT and MT decreased by 14% (p = 0.001) and 19% (p = 0.01), respectively. The proportions of all IS patients receiving IVT or MT remained unchanged, with, respectively, 17% versus 17% receiving IVT (p = 0.86) and 5% versus 5% receiving MT (p = 0.48). DNT and ODT were 24 versus 25 min (p = 0.58) and 168 versus 156 min (p = 0.23), respectively. NIHSS at admission did not differ (6 vs. 6; p = 0.54). CONCLUSION: Even with a low burden of COVID-19 during the first wave and no change in organization and logistics of stroke services, stroke admissions and volume of recanalization treatments decreased. Public health communication campaigns should encourage people to seek emergency medical care for stroke symptoms during the COVID-19 pandemic. S. Karger AG 2021-08-11 /pmc/articles/PMC8450853/ /pubmed/34515067 http://dx.doi.org/10.1159/000517968 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
spellingShingle | Clinical Research in Stroke Sedova, Petra Brown Jr., Robert D. Bryndziar, Tomas Jarkovsky, Jiri Tomek, Ales Sramek, Martin Skoda, Ondrej Sramkova, Tereza Littnerova, Simona Mikulik, Robert Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well |
title | Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well |
title_full | Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well |
title_fullStr | Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well |
title_full_unstemmed | Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well |
title_short | Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well |
title_sort | treat covid-19, but not only covid-19: stroke matters as well |
topic | Clinical Research in Stroke |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450853/ https://www.ncbi.nlm.nih.gov/pubmed/34515067 http://dx.doi.org/10.1159/000517968 |
work_keys_str_mv | AT sedovapetra treatcovid19butnotonlycovid19strokemattersaswell AT brownjrrobertd treatcovid19butnotonlycovid19strokemattersaswell AT bryndziartomas treatcovid19butnotonlycovid19strokemattersaswell AT jarkovskyjiri treatcovid19butnotonlycovid19strokemattersaswell AT tomekales treatcovid19butnotonlycovid19strokemattersaswell AT sramekmartin treatcovid19butnotonlycovid19strokemattersaswell AT skodaondrej treatcovid19butnotonlycovid19strokemattersaswell AT sramkovatereza treatcovid19butnotonlycovid19strokemattersaswell AT littnerovasimona treatcovid19butnotonlycovid19strokemattersaswell AT mikulikrobert treatcovid19butnotonlycovid19strokemattersaswell |